Market Insight – The changing face of drug screening
This article was originally published in Scrip
Executive Summary
In their constant efforts to develop better drugs more quickly, research-based pharmaceutical companies have an ongoing interest in any new technology that promises to show the way to drug discovery nirvana. Throughout the recent history of the industry, successive waves of technology have come along, each claiming to make the discovery process more rational and, as a result, more efficient.